KR20210131527A - Multifunctional non-alcoholic sanitizer and its manufacturing method - Google Patents
Multifunctional non-alcoholic sanitizer and its manufacturing method Download PDFInfo
- Publication number
- KR20210131527A KR20210131527A KR1020200049690A KR20200049690A KR20210131527A KR 20210131527 A KR20210131527 A KR 20210131527A KR 1020200049690 A KR1020200049690 A KR 1020200049690A KR 20200049690 A KR20200049690 A KR 20200049690A KR 20210131527 A KR20210131527 A KR 20210131527A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- extract
- composition
- niosome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 230000001476 alcoholic effect Effects 0.000 title description 12
- 239000000203 mixture Substances 0.000 claims abstract description 101
- 239000000645 desinfectant Substances 0.000 claims abstract description 77
- 239000000284 extract Substances 0.000 claims abstract description 54
- 239000002353 niosome Substances 0.000 claims abstract description 51
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 35
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 16
- 241000241413 Propolis Species 0.000 claims abstract description 16
- 229940069949 propolis Drugs 0.000 claims abstract description 16
- 229920001213 Polysorbate 20 Polymers 0.000 claims abstract description 10
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims abstract description 10
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims abstract description 10
- 229940068977 polysorbate 20 Drugs 0.000 claims abstract description 10
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 9
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 claims abstract description 9
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 9
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 claims abstract description 9
- 229940041616 menthol Drugs 0.000 claims abstract description 9
- 229940100573 methylpropanediol Drugs 0.000 claims abstract description 9
- 229960004025 sodium salicylate Drugs 0.000 claims abstract description 9
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract description 8
- 235000011187 glycerol Nutrition 0.000 claims abstract description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims abstract description 7
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims abstract description 7
- 239000002245 particle Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 5
- 239000005708 Sodium hypochlorite Substances 0.000 claims description 4
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 4
- 229960005076 sodium hypochlorite Drugs 0.000 claims description 3
- 230000032683 aging Effects 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 22
- 230000001954 sterilising effect Effects 0.000 abstract description 21
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 17
- 238000000034 method Methods 0.000 abstract description 9
- 230000035515 penetration Effects 0.000 abstract description 7
- 230000000774 hypoallergenic effect Effects 0.000 abstract description 5
- 238000012360 testing method Methods 0.000 description 20
- 241000894006 Bacteria Species 0.000 description 13
- 239000012528 membrane Substances 0.000 description 12
- 230000000844 anti-bacterial effect Effects 0.000 description 10
- 210000004379 membrane Anatomy 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 238000009472 formulation Methods 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 239000002736 nonionic surfactant Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 239000002105 nanoparticle Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000012085 test solution Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 241000186781 Listeria Species 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000012676 herbal extract Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000005445 natural material Substances 0.000 description 3
- 238000003921 particle size analysis Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 241000218642 Abies Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000218998 Salicaceae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 235000012377 Salvia columbariae var. columbariae Nutrition 0.000 description 1
- 240000005481 Salvia hispanica Species 0.000 description 1
- 235000001498 Salvia hispanica Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000014167 chia Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000002828 disc diffusion antibiotic sensitivity testing Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- -1 glycerin 1.2-hexanediol Sodium Salicylate Chemical compound 0.000 description 1
- 229940107702 grapefruit seed extract Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- PEFNSGRTCBGNAN-QNDFHXLGSA-N luteolin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-QNDFHXLGSA-N 0.000 description 1
- KBGKQZVCLWKUDQ-UHFFFAOYSA-N luteolin-glucoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC2=C1C(=O)C=C(C=1C=C(O)C(O)=CC=1)O2 KBGKQZVCLWKUDQ-UHFFFAOYSA-N 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
본 발명은 다기능 무알콜 소독제 조성물 및 조성물 제조방법에 관한 발명으로, 프로폴리스 추출물 10 ~ 20중량부와, 정향 추출물을 함유하는 니오좀 8 ~ 9중량부와, 포공영 추출물을 함유하는 니오좀 3 ~ 5중량부와, 글리세린 5 ~ 7중량부와, 1.2-헥산디올 2.5 ~ 3.5중량부와, 소듐살리실레이트 10 ~ 20중량부와, 다이소듐이디티에이 4.5 ~ 5.5중량부와, 메틸프로판디올 0.5 ~ 1중량부와, 멘톨 1.5 ~ 2.5중량부와, 부틸렌글라이콜 2.5 ~ 3.5중량부와, 폴리소르베이트-20 3 ~ 5중량부와, 잔량 전기분해수를 포함하는 다기능 무알콜 소독제 조성물을 구성함에 따라 종래의 알콜 기반의 소독제에 비해 저자극적이면서 유효성분의 높은 피부친화력 및 침투력을 제공하여 살균력 및 지속성이 우수한 소독제 조성물을 제조하는 것이 특징이다.The present invention relates to a multifunctional alcohol-free disinfectant composition and a method for preparing the composition, wherein 10 to 20 parts by weight of a propolis extract, 8 to 9 parts by weight of a niosome containing a clove extract, and 3 to 5 parts by weight of a niosome containing a pogongyeong extract parts by weight, 5 to 7 parts by weight of glycerin, 2.5 to 3.5 parts by weight of 1.2-hexanediol, 10 to 20 parts by weight of sodium salicylate, 4.5 to 5.5 parts by weight of disodium EDTA, and 0.5 parts by weight of methylpropanediol - 1 part by weight, 1.5 to 2.5 parts by weight of menthol, 2.5 to 3.5 parts by weight of butylene glycol, 3 to 5 parts by weight of polysorbate-20, and a multifunctional alcohol-free disinfectant composition comprising the remaining amount of electrolyzed water Accordingly, it is characterized in that it is hypoallergenic compared to conventional alcohol-based disinfectants and provides high skin affinity and penetration of active ingredients to prepare a disinfectant composition with excellent sterilization and durability.
Description
본 발명은 다기능 무알콜 소독제 조성물 및 조성물 제조방법에 관한 발명으로, 더욱 상세하게는 기존에 알콜 기반의 소독제와 차별하여 천연 유래 물질을 주성분으로 함유하는 무알콜 소독제 조성물을 제조하도록 구성함으로써 살균력이 우수하고 저자극적인 소독제의 제공에 관한 것이다.The present invention relates to a multifunctional non-alcoholic disinfectant composition and a method for manufacturing the composition, and more particularly, it has excellent sterilization power and is distinguished from existing alcohol-based disinfectants to prepare a non-alcoholic disinfectant composition containing a natural substance as a main component. It is about the provision of a dramatic disinfectant.
일반적으로, 소독제는 각종 감염병을 예방하기 위하여 물에 세척하는 것을 대신해 바르거나 문질러 살균 및 세척 효과를 도모하도록 마련된 약제이다.In general, a disinfectant is a drug prepared to promote sterilization and cleaning effect by applying or rubbing instead of washing with water in order to prevent various infectious diseases.
소독제는 주로 의료기관에서 감염에 취약한 환자에게 외과적으로 미생물 등이 침입하는 것을 예방하기 위한 목적으로 사용하였으나 최근에는 각종 인플루엔자 등의 전염병이나 감염병이 범유행하는 양상이 빈번해짐에 따라 일반인들도 소독제나 세정제 등에 대한 관심이 증가하고 있는 추세이다.Disinfectants were mainly used in medical institutions for the purpose of preventing the intrusion of microorganisms surgically into patients who are vulnerable to infection. Interest in detergents and the like is increasing.
통상적으로 사용되는 소독제는 튜브나 펌프에 보관하여 사용하기 편하도록 액체 또는 젤 타입의 제품으로 제공되며 살균 효과를 발휘하도록 약 60 ~ 80%의 알콜과 그 밖의 각종 화학물질의 조성으로 이루어진다.Disinfectants commonly used are provided in liquid or gel-type products for easy use by keeping them in tubes or pumps, and consist of about 60 to 80% alcohol and other various chemicals to exert a sterilizing effect.
소독제의 주성분인 알콜은 에탄올 또는 아이소프로판을 적용하여 각종 바이러스, 박테리아, 세균, 곰팡이 등을 제거하도록 작용한다.Alcohol, the main component of the disinfectant, works to remove various viruses, bacteria, bacteria, molds, etc. by applying ethanol or isopropane.
공지된 기술의 일례로서, 한국등록특허 제 10 - 1284045 호에는 무수 말레산계 고분자 0.01 ~ 2.0중량%와, 셀룰로스계 수용성 고분자인 다당류 0.01 ~ 5.0중량%와, 메탄올, 에탄올 및 이소프로판올에서 선택되는 적어도 1종으로 이루어지는 저급 알콜 40 ~ 95중량%와, 2-(메타)아크릴로일옥시에틸포스포릴콜린 함유 중합체 0.001 ~ 10중량%와, 물을 포함하고, pH 및 점도조정제, 살균소독약, 보습제 및 이들의 혼합물로 이루어지는 군으로부터 선택되는 1종 또는 2종 이상의 첨가제를 더 포함하는 겔상 손가락 소독제를 구성한다.As an example of a known technique, Korean Patent Registration No. 10-1284045 discloses 0.01 to 2.0% by weight of a maleic anhydride-based polymer, 0.01 to 5.0% by weight of a cellulosic water-soluble polysaccharide, and at least one selected from methanol, ethanol and isopropanol. 40 to 95% by weight of a lower alcohol consisting of a species, 0.001 to 10% by weight of a polymer containing 2-(meth)acryloyloxyethylphosphorylcholine, water, pH and viscosity modifiers, disinfectants, humectants, and these It constitutes a gel-like finger disinfectant further comprising one or two or more additives selected from the group consisting of a mixture of
다른 예로서, 한국등록특허 제 10 - 1583850 호에는 유화제 및 연화제, 실리콘 및 이들의 혼합물로 이루어진 그룹으로부터 선택되는 피부 보호제를 포함하는 고 내상 에멀젼 0.1 ~ 10중량%와, 메탄올, 에탄올, 프로판올, 이소프로필 알콜, 부탄올, t-부탄올, 2-부탄올, 펜타놀, 헥사놀 및 이들의 혼합물로 이루어진 그룹으로부터 선택되는 알콜 20 ~ 95중량%와, 물과, 습윤제와, 살균제, 점도 증가제, 방향제, pH 조절제, 피부 컨디셔닝 제제 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 성분을 더 포함하는 보습 손 세정제를 구성한다.As another example, Korean Patent Registration No. 10 - 1583850 discloses an emulsifier and an emollient, a silicone, and a skin protectant selected from the group consisting of mixtures of 0.1 to 10% by weight of a high internal phase emulsion, methanol, ethanol, propanol, iso 20 to 95% by weight of an alcohol selected from the group consisting of propyl alcohol, butanol, t-butanol, 2-butanol, pentanol, hexanol, and mixtures thereof, with water, a wetting agent, a disinfectant, a viscosity increasing agent, a perfume; A moisturizing hand sanitizer further comprising an ingredient selected from the group consisting of pH adjusting agents, skin conditioning agents, and mixtures thereof.
또 다른 예로서, 한국등록특허 제 10 - 1196113 호에는 무수에탄올을 계량하여 에센셜 오일과 혼합하여 무수에탄올 및 에센셜 오일 제1혼합수를 제조하는 단계와, 제1혼합수에 한방추출물, 알로에베라겔, 히알루론산, 자몽씨추출물, 정제수를 혼합하는 제2혼합수를 제조하는 단계와, 제2혼합수를 용기에 포장하여 상온에서 1 내지 2일 보관하는 포장 및 보관하는 단계로 이루어지는 천연한방추출물을 포함하는 손세정제 제조방법을 구성한다.As another example, Korean Patent Registration No. 10 - 1196113 discloses a step of measuring anhydrous ethanol and mixing it with essential oil to prepare anhydrous ethanol and a first mixed water of essential oil, and an herbal extract, aloe vera gel, Contains a natural herbal extract comprising the steps of preparing a second mixed water mixing hyaluronic acid, grapefruit seed extract, and purified water, and packaging and storing the second mixed water in a container and storing it at room temperature for 1 to 2 days constitute a method for manufacturing hand sanitizer that
상기와 같은 종래 기술이 적용되는 소독제는 에탄올 또는 아이소프로판과 같은 알콜 60 ~ 80%를 주성분으로 함유하여 살균 작용이 이루어지도록 하고, 그 밖에 피부 보습제나 물성 조성을 위한 유화제 등의 화학물질을 포함하는 형태로 이루어진다.The disinfectant to which the prior art as described above is applied contains 60 to 80% of alcohol such as ethanol or isopropane as a main component to achieve a sterilization action, and other forms containing chemicals such as skin moisturizers or emulsifiers for physical properties is made of
그러나, 종래의 소독제는 알콜의 강한 휘발성 및 자극성으로 인해 피부가 약하고 민감한 사람이 사용 시 홍반, 발진 등의 각종 부작용을 유발할 수 있으며 눈, 구강, 점막이나 상처가 있는 부위에 사용할 경우 심한 자극을 동반하게 되는 문제점이 있다.However, conventional disinfectants can cause various side effects such as erythema and rash when used by people with weak and sensitive skin due to the strong volatility and irritation of alcohol, and when used in the eyes, mouth, mucous membranes or areas with wounds, severe irritation is accompanied. There is a problem to do.
이와 같은 문제점으로 인해 또 다른 예로 든 종래 기술에서와 같이 한방추출물이나 알로에베라와 같은 살균 작용을 하는 것으로 알려진 천연 성분을 함유하는 소독제 제조 기술이 제공되고 있다.Due to this problem, as in the prior art as another example, a disinfectant manufacturing technique containing a natural ingredient known to have a bactericidal action, such as an herbal extract or aloe vera, is provided.
그러나, 천연 성분과 화학 성분을 혼합하여 소독제를 조성하는 과정에서 유화제나 습윤제를 사용하더라도 유효성분의 제형이 불안정하게 조성되는 단점이 있으므로 사용 시 피부친화력 및 침투력이 약하고 알콜 기반의 소독제에 비해 충분한 살균력을 확보하기 어려운 문제점을 내포한다.However, even if an emulsifier or a wetting agent is used in the process of mixing natural and chemical ingredients to form a disinfectant, the formulation of the active ingredient is unstable. It contains problems that are difficult to obtain.
이에 본 발명에서는 상술한 바와 같은 종래 기술의 문제점을 해결하기 위하여 발명한 것으로서,Accordingly, the present invention was invented to solve the problems of the prior art as described above,
프로폴리스 추출물 10 ~ 20중량부와, 정향 추출물을 함유하는 니오좀 8 ~ 9중량부와, 포공영 추출물을 함유하는 니오좀 3 ~ 5중량부와, 글리세린 5 ~ 7중량부와, 1.2-헥산디올 2.5 ~ 3.5중량부와, 소듐살리실레이트 10 ~ 20중량부와, 다이소듐이디티에이 4.5 ~ 5.5중량부와, 메틸프로판디올 0.5 ~ 1중량부와, 멘톨 1.5 ~ 2.5중량부와, 부틸렌글라이콜 2.5 ~ 3.5중량부와, 폴리소르베이트-20 3 ~ 5중량부와, 잔량 전기분해수를 포함하여 구성함으로써 저자극적이면서 유효성분의 높은 피부친화력 및 침투력을 제공하여 살균력 및 지속성이 우수한 무알콜 소독제 조성물을 제조할 수 있는 목적 달성이 가능하다.10 to 20 parts by weight of propolis extract, 8 to 9 parts by weight of niosome containing clove extract, 3 to 5 parts by weight of niosome containing pogongyeong extract, 5 to 7 parts by weight of glycerin, and 1.2-hexanediol 2.5 to 3.5 parts by weight, 10 to 20 parts by weight of sodium salicylate, 4.5 to 5.5 parts by weight of disodium EDTA, 0.5 to 1 part by weight of methylpropanediol, 1.5 to 2.5 parts by weight of menthol, and butylene; By containing 2.5 to 3.5 parts by weight of Lycol, 3 to 5 parts by weight of Polysorbate-20, and the remaining amount of electrolyzed water, it is hypoallergenic and provides high skin affinity and penetration of active ingredients, and is non-alcoholic with excellent sterilization and durability. It is possible to achieve the purpose of preparing a disinfectant composition.
본 발명은 살균 및 항균, 해독 등의 작용을 하는 것으로 알려진 천연 유래 성분인 프로폴리스, 정향, 포공영을 유효성분으로 함유하는 무알콜 소독제 조성물을 제조하도록 한다.The present invention is to prepare a non-alcoholic disinfectant composition containing propolis, cloves, and pogongyeong, which are natural ingredients known to have sterilization, antibacterial, detoxification, and the like, as active ingredients.
따라서, 본 발명은 약 60 ~ 80%가 알콜 성분으로 이루어진 종래의 소독제에 비해 저자극적이면서도 살균력이 우수한 소독제 조성물을 제조하므로 피부가 민감한 사람도 안심하고 사용할 수 있는 소독제를 제공하는 효과가 있다.Therefore, the present invention produces a disinfectant composition that is hypoallergenic and has excellent sterilization power compared to a conventional disinfectant containing about 60 to 80% alcohol, so that it is effective to provide a disinfectant that can be safely used even by people with sensitive skin.
또한, 본 발명은 유효성분의 효과적인 작용을 도출하도록 비이온성 계면활성제를 활용한 이중막 수송체인 니오좀 기술을 적용하여 나노 크기의 유효성분 전달체계를 형성함으로써 높은 탄력성 및 분산 안정성을 가지는 제형의 소독제 조성물을 제조하는 이점이 있다.In addition, the present invention is a disinfectant of a formulation having high elasticity and dispersion stability by forming a nano-sized active ingredient delivery system by applying niosome technology, which is a double-membrane transporter using a non-ionic surfactant to derive an effective action of the active ingredient. There are advantages to preparing the composition.
따라서, 본 발명은 종래 기술에 비해 높은 피부친화력 및 침투력을 제공하고 극성 및 비극성 성분 봉입 능력을 확보하도록 하여 사용감 및 살균력이 우수하며 유효성분의 산화 및 변성을 방지함으로써 효력의 지속성이 향상된 소독제 조성물을 제조할 수 있는 효과를 가진다.Therefore, the present invention provides a high skin affinity and penetrability compared to the prior art, and secures the ability to encapsulate polar and non-polar components, so that the feeling of use and sterilization is excellent, and by preventing oxidation and denaturation of active ingredients, a disinfectant composition with improved durability It has a manufacturing effect.
도 1은 본 발명에 따른 다기능 무알콜 소독제 조성물에 함유되는 정향의 항균 활성 시험 결과 이미지.
도 2는 본 발명에 따른 다기능 무알콜 소독제 조성물에 함유되는 정향 추출물 및 포공영 추출물을 함유하는 니오좀의 입자 크기 분석 시험 결과 이미지.
도 3 내지 도 5는 본 발명에 따른 다기능 무알콜 소독제 조성물의 살균력 측정 시험 보고서 이미지.1 is an image of an antimicrobial activity test result of cloves contained in a multifunctional alcohol-free disinfectant composition according to the present invention.
Figure 2 is an image of the particle size analysis test result of niosomes containing clove extract and pogongyeong extract contained in the multifunctional alcohol-free disinfectant composition according to the present invention.
3 to 5 are images of a test report for measuring the sterilization power of the multifunctional alcohol-free disinfectant composition according to the present invention.
이하, 본 발명의 다기능 무알콜 소독제 조성물 및 조성물 제조방법의 바람직한 실시 예에 따른 구성과 작용을 첨부 도면을 참조하여 상세히 설명하면 다음과 같다. 하기의 설명에서 당해 기술분야의 통상의 기술자가 용이하게 구현할 수 있는 부분에 대한 구체적인 설명은 생략될 수 있다. 아울러 하기의 설명은 본 발명에 대하여 바람직한 실시 예를 들어 설명하는 것이므로 본 발명은 하기 실시 예에 의해 한정되는 것이 아니며 본 발명의 범주를 벗어나지 않는 범위 내에서 다양한 변형이 제공될 수 있음은 당연하다 할 것이다.Hereinafter, the composition and action according to a preferred embodiment of the multifunctional non-alcoholic disinfectant composition and method for preparing the composition of the present invention will be described in detail with reference to the accompanying drawings. In the following description, a detailed description of a part that can be easily implemented by a person skilled in the art may be omitted. In addition, since the following description is given by way of a preferred embodiment of the present invention, the present invention is not limited by the following examples, and it is natural that various modifications may be provided within the scope of the present invention. will be.
도 1은 본 발명에 따른 다기능 무알콜 소독제 조성물에 함유되는 정향의 항균 활성 시험 결과 이미지, 도 2는 본 발명에 따른 다기능 무알콜 소독제 조성물에 함유되는 정향 추출물 및 포공영 추출물을 함유하는 니오좀의 입자 크기 분석 시험 결과 이미지, 도 3 내지 도 5는 본 발명에 따른 다기능 무알콜 소독제 조성물의 살균력 측정 시험 보고서 이미지를 도시한 것이다.1 is an image of an antibacterial activity test result of cloves contained in a multifunctional non-alcoholic disinfectant composition according to the present invention, FIG. 2 is a particle size analysis of niosomes containing a clove extract and pogongyeong extract contained in a multifunctional alcohol-free disinfectant composition according to the present invention The test result image, FIGS. 3 to 5 shows an image of a test report for measuring the sterilization power of the multifunctional alcohol-free disinfectant composition according to the present invention.
본 발명의 기술이 적용되는 다기능 무알콜 소독제 조성물 및 조성물 제조방법은 종래 알콜 기반의 소독제와 차별하여 천연 유래 물질을 유효성분으로 함유하는 무알콜 소독제 조성물을 제조하도록 이루어짐으로써 살균력이 우수하고 저자극적인 소독제의 제공에 관한 것임을 주지한다.The multifunctional non-alcoholic disinfectant composition to which the technology of the present invention is applied and the method for producing the composition are differentiated from conventional alcohol-based disinfectants to prepare a non-alcoholic disinfectant composition containing a natural substance as an active ingredient, thereby providing an excellent sterilizing power and hypoallergenic disinfectant Note that it is about
이를 위한 본 발명의 소독제 조성물은 프로폴리스 추출물 10 ~ 20중량부와, 정향 추출물을 함유하는 니오좀 8 ~ 9중량부와, 포공영 추출물을 함유하는 니오좀 3 ~ 5중량부와, 글리세린 5 ~ 7중량부와, 1.2-헥산디올 2.5 ~ 3.5중량부와, 소듐살리실레이트 10 ~ 20중량부와, 다이소듐이디티에이 4.5 ~ 5.5중량부와, 메틸프로판디올 0.5 ~ 1중량부와, 멘톨 1.5 ~ 2.5중량부와, 부틸렌글라이콜 2.5 ~ 3.5중량부와, 폴리소르베이트-20 3 ~ 5중량부와, 잔량 전기분해수를 포함하여 구성한다.For this purpose, the disinfectant composition of the present invention contains 10 to 20 parts by weight of propolis extract, 8 to 9 parts by weight of niosome containing clove extract, 3 to 5 parts by weight of niosome containing pogongyeong extract, and 5 to 7 parts by weight of glycerin. Parts by weight, 2.5 to 3.5 parts by weight of 1.2-hexanediol, 10 to 20 parts by weight of sodium salicylate, 4.5 to 5.5 parts by weight of disodium EDTA, 0.5 to 1 part by weight of methylpropanediol, and 1.5 parts by weight of menthol ~ 2.5 parts by weight, 2.5 to 3.5 parts by weight of butylene glycol, 3 to 5 parts by weight of polysorbate-20, and the remaining amount of electrolyzed water.
상기 프로폴리스는 벌이 벌집을 짓는 과정에서 소나무, 전나무, 버드나무 등의 식물에서 채취한 수액 및 꽃의 화분과 벌의 타액과 밀랍 등의 분비물을 섞어 만든 물질이다. 프로폴리스에는 미네랄, 비타민, 아미노산, 이방, 유기산, 플라보노이드, 테르펜 등의 성분을 함유하여 예로부터 세균이나 바이러스, 박테리아에 대한 천연항생물질로 사용되었다.The propolis is a substance made by mixing secretions such as sap, flower pollen, bee saliva, and wax collected from plants such as pine trees, fir trees, and willows during the process of bees building a honeycomb. Since propolis contains ingredients such as minerals, vitamins, amino acids, anisotropics, organic acids, flavonoids, and terpenes, it has been used as a natural antibiotic against bacteria, viruses, and bacteria since ancient times.
상기 프로폴리스 추출물은 벌집에서 채취한 프로폴리스를 용매로 추출한 후 밀랍을 여과하여 정제하고 농축하여 수득한다. 프로폴리스 추출에 사용되는 용매는 물 또는 유기용매를 적용할 수 있을 것이다.The propolis extract is obtained by extracting propolis collected from a honeycomb with a solvent, filtration, purification, and concentration of beeswax. The solvent used for propolis extraction may be water or an organic solvent.
상기 프로폴리스 추출물은 소독제 조성물 총 중량에 대해 10 ~ 20중량부를 첨가하여 감염예방 및 치료, 항염 작용은 물론 악취 및 부패 방지 작용이 이루어지도록 구성한다.The propolis extract is composed of 10 to 20 parts by weight based on the total weight of the disinfectant composition to prevent infection and treatment, and to prevent odor and decay as well as anti-inflammatory action.
상기 정향은 정향나무의 꽃봉오리로써 적갈색의 화상과 꽃받침과 꽃잎과 수술 및 암술을 포함한다. 정향에는 유제놀, 베타캐리오필렌, 바닐린, 타닌 등의 항산화 성분 및 칼슘과 비타민을 풍부하게 함유하여 항염 및 살균, 소염제로 사용하였다. The clove is a bud of a clove tree and includes reddish-brown burns, sepals, petals, stamens, and pistils. Cloves are rich in antioxidants such as eugenol, beta-caryophyllene, vanillin, and tannin, as well as calcium and vitamins, and are used as anti-inflammatory, sterilizing and anti-inflammatory agents.
상기 정향 추출물은 건조한 정향을 용매로 추출한 후 용매를 정제하고 가수분해효소로 처리하여 수득한다. 정향 추출에 사용되는 용매는 물 또는 유기용매를 적용할 수 있을 것이다. The clove extract is obtained by extracting dried cloves with a solvent, purifying the solvent, and treating with a hydrolase. The solvent used for extracting cloves may be water or an organic solvent.
한편, 본 발명에 따른 소독제 조성물에는 상기 정향 추출물을 니오좀의 형태로 가공하여 함유하도록 구성한다.On the other hand, the disinfectant composition according to the present invention is configured to contain the clove extract by processing in the form of niosomes.
상기 정향 추출물을 함유하는 니오좀은 비이온성 계면활성제와 콜레스테롤을 유화시켜 미세 크기의 이중막 구조의 니오좀을 수득하고, 정향 추출물을 니오좀 내부에 포획하여 나노 입자의 제형으로 안정화함으로써 수득한다.The niosomes containing the clove extract are obtained by emulsifying a nonionic surfactant and cholesterol to obtain a niosome having a micro-sized double membrane structure, and capturing the clove extract inside the niosome and stabilizing it in a nanoparticle formulation.
상기 정향 추출물을 함유하는 니오좀은 비이온성 계면활성제 기반의 소포로서 친수성 말단이 바깥 쪽을 향하고 소수성 말단이 서로 마주하여 이중막을 형성하는 구조로 이루어진다. 니오좀은 이중막 구조를 가지는 점에서 리포좀과 유사하지만 니오좀은 수성 또는 지질로 이루어진 막 내부에 친수성 및 친유성 유효성분을 모두 포획하여 안정성이 우수하다. 상기 정향 추출물을 함유하는 니오좀은 입자의 크기를 나노 수준으로 조절하여 평균 입도가 50 ~ 500nm로 조성함으로써 유효성분의 높은 전달, 침투력을 발휘하도록 구성한다.The niosomes containing the clove extract are nonionic surfactant-based vesicles with a hydrophilic end facing outward and a hydrophobic end facing each other to form a double membrane. Niosomes are similar to liposomes in that they have a double membrane structure, but niosomes have excellent stability by capturing both hydrophilic and lipophilic active ingredients in an aqueous or lipid membrane. The niosome containing the clove extract is configured to exhibit high delivery and penetration of the active ingredient by controlling the particle size to a nano level and having an average particle size of 50 to 500 nm.
상기 정향 추출물을 함유하는 니오좀은 소독제 조성물 총 중량에 대해 8 ~ 9중량부를 첨가하여 박테리아, 세균 등을 사멸 및 억제 방부 작용 피부 노화 방지 작용이 이루어지도록 구성한다.The niosome containing the clove extract is configured to kill and inhibit bacteria, bacteria, etc. by adding 8 to 9 parts by weight based on the total weight of the disinfectant composition, so as to have an antiseptic action and an anti-aging action on the skin.
상기 포공영은 국화과의 민들레 전초를 건조한 것으로 플라보노이드, 루테올린-글루코시드, 카로틴, 아스코르브산, 비타민 등을 함유하여 세균 억제, 소염, 항균, 항알러지제로 사용하였다.The pogongyeong is a dried dandelion outpost of the Asteraceae family and contains flavonoids, luteolin-glucoside, carotene, ascorbic acid, vitamins, and the like, and was used as an antibacterial, anti-inflammatory, antibacterial, and anti-allergic agent.
상기 포공영 추출물은 건조된 포공영을 용매로 추출한 후 용매를 정제하고 농축하여 수득한다. 포공영 추출에 사용되는 용매는 물 또는 유기용매를 적용할 수 있을 것이다.The pogongyeong extract is obtained by extracting the dried pogongyeong with a solvent, purifying the solvent, and then concentrating. Water or an organic solvent may be applied as the solvent used for the pore extraction.
본 발명에 따른 소독제 조성물에는 상기 포공영 추출물을 니오좀의 형태로 가공하여 함유하도록 구성한다.The disinfectant composition according to the present invention is configured to contain the pogongyeong extract by processing it in the form of niosomes.
상기 포공영 추출물을 함유하는 니오좀은 비이온성 계면활성제와 콜레스테롤을 유화시켜 미세 크기의 이중막 구조의 니오좀을 수득하고, 포공영 추출물을 니오좀 내부에 포획하여 나노 입자의 제형으로 안정화함으로써 수득한다.The niosome containing the pogongyeong extract is obtained by emulsifying a nonionic surfactant and cholesterol to obtain a niosome having a micro-sized double membrane structure, and capturing the pogongyeong extract inside the niosome and stabilizing it in a nanoparticle formulation.
상기 포공영 추출물을 함유하는 니오좀은 비이온성 계면활성제 기반의 소포로서 친수성 말단이 바깥 쪽을 향하고 소수성 말단이 서로 마주하여 이중막을 형성하는 구조로 이루어진다. 니오좀은 이중막 구조를 가지는 점에서 리포좀과 유사하지만 니오좀은 수성 또는 지질로 이루어진 막 내부에 친수성 및 친유성 유효성분을 모두 포획하여 안정성이 우수하다. 상기 포공영 추출물을 함유하는 니오좀은 입자의 크기를 나노 수준으로 조절하여 평균 입도가 50 ~ 500nm로 조성함으로써 유효성분의 높은 전달, 침투력을 발휘하도록 구성한다.The niosomes containing the pogongyeong extract are nonionic surfactant-based vesicles with a hydrophilic end facing outward and a hydrophobic end facing each other to form a double membrane. Niosomes are similar to liposomes in that they have a double membrane structure, but niosomes have excellent stability by capturing both hydrophilic and lipophilic active ingredients in an aqueous or lipid membrane. The niosome containing the pogongyeong extract is configured to exhibit high delivery and penetration of active ingredients by controlling the particle size to a nano level and having an average particle size of 50 to 500 nm.
상기 포공영 추출물을 함유하는 니오좀은 소독제 조성물 총 중량에 대해 3 ~ 5중량부를 첨가하여 항산화 및 해독 작용이 이루어지도록 구성한다. The niosome containing the pogongyeong extract is configured to have antioxidant and detoxifying action by adding 3 to 5 parts by weight based on the total weight of the disinfectant composition.
상기 글리세린은 피부에 수분을 보급하고 소독제 자체의 건조화를 예방하도록 소독제 조성물 총 중량에 대해 5 ~ 7중량부를 함유하도록 구비한다.The glycerin is provided to contain 5 to 7 parts by weight based on the total weight of the disinfectant composition to supply moisture to the skin and prevent drying of the disinfectant itself.
상기 1.2-헥산디올(1.2-Hexandiol)은 무색무취의 천연보습 및 항균성과 진균방부제 작용을 하도록 소독제 조성물 총 중량에 대해 2.5 ~ 3.5중량부를 함유하도록 구비한다.The 1.2-hexanediol (1.2-Hexandiol) is prepared to contain 2.5 to 3.5 parts by weight based on the total weight of the disinfectant composition so as to act as a colorless and odorless natural moisturizing, antibacterial and antifungal agent.
상기 소듐살리실레이트(Sodium Salicylate)는 변성제 및 살균보존제 작용을 하도록 소독제 조성물 총 중량에 대해 10 ~ 20중량부를 함유하도록 구비한다.The sodium salicylate (Sodium Salicylate) is provided so as to contain 10 to 20 parts by weight based on the total weight of the disinfectant composition to act as a denaturant and sterilizing preservative.
상기 다이소듐이디티에이(Disodium EDTA)는 세균 감염 및 산화 방지제, 침전물의 발생을 억제하여 안전성을 확보하도록 소독제 조성물 총 중량에 대해 4.5 ~ 5.5중량부를 함유하도록 구비한다.The disodium EDTA is provided so as to contain 4.5 to 5.5 parts by weight based on the total weight of the disinfectant composition in order to secure safety by inhibiting bacterial infection, antioxidant, and the generation of deposits.
상기 메틸프로판디올(Methylpropanediol)은 무색무취의 유기용매 및 용제, 보습제로 작용하도록 소독제 조성물 총 중량에 대해 0.5 ~ 1중량부를 함유하도록 구비한다.The methylpropanediol is prepared to contain 0.5 to 1 part by weight based on the total weight of the disinfectant composition to act as a colorless and odorless organic solvent, solvent, and moisturizer.
상기 멘톨은 상쾌감, 청량감을 부여하고 보습 효과를 부여하도록 소독제 조성물 총 중량에 대해 1.5 ~ 2.5중량부를 함유하도록 구비한다.The menthol is provided so as to contain 1.5 to 2.5 parts by weight based on the total weight of the disinfectant composition so as to give a refreshing feeling and a refreshing feeling and to provide a moisturizing effect.
상기 부틸렌글라이콜(Butylene Glycol)은 용제 및 보습제, 점도감소제, 피부컨디셔닝제로 작용하도록 소독제 조성물 총 중량에 대해 2.5 ~ 3.5중량부를 함유하도록 구비한다.The butylene glycol is provided so as to contain 2.5 to 3.5 parts by weight based on the total weight of the disinfectant composition to act as a solvent, a moisturizer, a viscosity reducing agent, and a skin conditioning agent.
상기 폴리소르베이트-20(Polysorbate 20)는 상술한 바와 같은 본 발명의 소독제 조성물을 구성하는 천연 및 화학 물질과 같이 서로 잘 혼합되지 않는 성분들을 균일하게 분산하여 유화 안정이 이루어지도록 작용하며, 소독제 조성물 총 중량에 대해 3 ~ 5중량부를 함유하도록 구비한다.The polysorbate-20 (Polysorbate 20) acts to achieve emulsion stability by uniformly dispersing ingredients that do not mix well with each other, such as natural and chemical substances constituting the disinfectant composition of the present invention as described above, and the disinfectant composition It is provided so as to contain 3 to 5 parts by weight based on the total weight.
상기 전기분해수는 물에 음극 및 양극 전류를 가하여 전기 분해 반응을 유도함으로써 산화체를 단시간에 생성하여 세균이나 박테리아를 살균하고 보존제로 작용하도록 적당량을 함유하도록 구비한다.The electrolyzed water is provided to contain an appropriate amount to sterilize bacteria or bacteria and act as a preservative by generating an oxidizer in a short time by inducing an electrolysis reaction by applying negative and positive currents to water.
아울러, 본 발명의 소독제 조성물에는 소독 및 방취, 부패 및 병원균의 사멸 작용을 도모하도록 차아염소산나트륨(HCLO)을 함유하도록 구비한다.In addition, the disinfectant composition of the present invention is provided to contain sodium hypochlorite (HCLO) to promote disinfection and deodorization, decay, and killing of pathogens.
이하에서는 전술한 바와 같은 구성으로 이루어지는 본 발명의 기술이 적용된 다기능 무알콜 소독제 조성물 제조방법을 살펴본다. Hereinafter, a method for producing a multifunctional alcohol-free disinfectant composition to which the technology of the present invention is applied having the configuration as described above will be described.
상기 제1혼합물을 조성하는 단계는 소듐살리실레이트와, 글리세린과, 1.2-헥산디올을 실온에서 10 ~ 20분간 교반하는 단계이다.The step of composing the first mixture is a step of stirring sodium salicylate, glycerin, and 1.2-hexanediol at room temperature for 10 to 20 minutes.
상기 제1혼합물을 조성하는 단계는 수상에서 실시하는 바, 전기분해수를 이용하여 살균 및 보존력을 부여하도록 구성하며 결과물로 도출되는 소독제 조성물 총 중량에 대하여 소듐살리실레이트 10 ~ 20중량부와, 글리세린 5 ~ 7중량부와, 1.2-헥산디올 2.5 ~ 3.5중량부를 배합하고 저속 교반하여 제1혼합물을 조성한다.The step of composing the first mixture is carried out in the aqueous phase, and is configured to impart sterilization and preservative power using electrolyzed water, and 10 to 20 parts by weight of sodium salicylate based on the total weight of the resulting disinfectant composition; 5 to 7 parts by weight of glycerin and 2.5 to 3.5 parts by weight of 1.2-hexanediol are mixed and stirred at low speed to form a first mixture.
상기 제2혼합물을 수득하는 단계는 프로폴리스와, 부틸렌글라이콜과, 폴리소르베이트-20을 45℃에서 5분간 교반하는 단계이다.The step of obtaining the second mixture is a step of stirring propolis, butylene glycol, and polysorbate-20 at 45° C. for 5 minutes.
상기 제2혼합물을 수득하는 단계에서는 천연 유효 성분으로써 프로폴리스 추출물 10 ~ 20중량부와, 부틸렌그라이콜 2.5 ~ 3.5중량부와, 폴리소르베이트-20 3 ~ 5중량부를 배합하고 호모믹서를 이용해 1500rpm으로 교반하여 제2혼합물을 조성한다.In the step of obtaining the second mixture, 10 to 20 parts by weight of propolis extract, 2.5 to 3.5 parts by weight of butylene glycol, and 3 to 5 parts by weight of polysorbate-20 are blended as a natural active ingredient and using a homomixer A second mixture is prepared by stirring at 1500 rpm.
상기 1차조성물을 조성하는 단계는 상기와 같이 조성되는 제1혼합물에 제2혼합물을 첨가하여 1차조성물을 조성하는 단계이다.The step of composing the first composition is a step of forming the first composition by adding the second mixture to the first mixture prepared as described above.
상기 2차조성물을 수득하는 단계는 상기와 같은 제1혼합물 및 제2혼합물에 의해 조성되는 1차조성물에, 정향 추출물을 함유하는 니오좀과, 포공영 추출물을 함유하는 니오좀과, 다이소듐이디티에이와, 멘톨과, 차아염소산나트륨과, 메틸프로판디올을 첨가하고 실온에서 10분간 혼합하여 2차조성물을 수득하는 단계이다.In the step of obtaining the secondary composition, a niosome containing a clove extract, a niosome containing a pogongyeong extract, and a disodium edti A, menthol, sodium hypochlorite, and methylpropanediol are added and mixed at room temperature for 10 minutes to obtain a secondary composition.
상기 2차조성물을 수득하는 단계에서는 천연 유효 성분으로써 정향 추출물을 함유하는 니오좀 8 ~ 9중량부와, 포공영 추출물을 함유하는 니오좀 3 ~ 5중량부와, 다이소듐이디티에이 4.5 ~ 5.5중량부와, 멘톨 1.5 ~ 2.5중량부와, 차아염소산나트륨 및 메틸프로판디올을 적당량 배합하고 호모믹서를 이용해 800rpm으로 혼합하여 2차조성물을 수득한다.In the step of obtaining the secondary composition, 8 to 9 parts by weight of niosome containing clove extract as a natural active ingredient, 3 to 5 parts by weight of niosome containing pogongyeong extract, and 4.5 to 5.5 weight of disodium EDTA Part and 1.5 to 2.5 parts by weight of menthol, sodium hypochlorite and methylpropanediol are mixed in an appropriate amount and mixed at 800 rpm using a homomixer to obtain a secondary composition.
상기 2차조성물을 수득하는 단계에 투입되는 정향 추출물을 함유하는 니오좀 및 포공영 추출물을 함유하는 니오좀은 비이온성 계면활성제와 콜레스테롤을 유화시켜 미세 크기의 이중막 구조의 니오좀을 수득하고, 정향 추출물 및 포공영 추출물을 각각의 니오좀 내부에 포획하여 나노 입자의 제형으로 안정화하는 과정을 거쳐 수득한다. 니오좀의 형성 기제에 관해서는 주지된 관련 기술을 참고하면 될 것이므로 구체적인 설명은 생략한다.Niosomes containing clove extract and niosomes containing pogongyeong extract, which are added to the step of obtaining the secondary composition, are emulsified with a nonionic surfactant and cholesterol to obtain niosomes having a fine-sized double membrane structure, and cloves The extract and the pogongyeong extract are captured inside each niosome and obtained through a process of stabilizing the nanoparticle formulation. As for the formation mechanism of niosomes, reference will be made to the well-known related art, and thus a detailed description thereof will be omitted.
본 발명에 따른 다기능 무알콜 소독제 조성물의 유효 성분을 함유하는 정향 및 포공영 추출물을 니오좀의 제형으로 투입하는 것은 니오좀이 이중막 내부에 친수성 및 친유성 유효성분을 모두 포획하여 안정성을 확보하고 니오좀의 입자의 크기를 나노 수준으로 조절함으로써 유효성분의 높은 전달, 침투력을 발휘하도록 하기 위함이다.Injecting clove and porgongyeong extract containing the active ingredient of the multifunctional alcohol-free disinfectant composition according to the present invention into the formulation of niosomes ensures stability by capturing both hydrophilic and lipophilic active ingredients inside the double membrane and niosomes. This is in order to exert high delivery and penetration of active ingredients by controlling the size of the particles at the nano level.
상기와 같이 수득한 2차조성물은 실온으로 냉각하고 180 ~ 220메쉬 필터로 여과하는 단계와, 여과된 2차조성물을 저장 및 숙성하여 소독제 조성물을 수득하는 단계를 거쳐 최종 결과물로서 다기능 무알콜 소독제 조성물을 제조한다.The secondary composition obtained as described above is cooled to room temperature and filtered through a 180-220 mesh filter, and after storing and aging the filtered secondary composition to obtain a disinfectant composition, a multifunctional alcohol-free disinfectant composition as a final product is obtained. manufacture
이하에서는 전술한 바와 같은 구성으로 이루어지는 본 발명을 포함하는 실시 예 및 시험 예를 구성하고 그에 따른 효과에 대해서 면밀하게 파악하고자 한다.Hereinafter, embodiments and test examples including the present invention having the configuration as described above will be constructed, and the effects thereof will be understood in detail.
<실시 예><Example>
상술한 바와 같은 본 발명에 따른 제1혼합물을 조성하는 단계 내지 소독제 조성물을 수득하는 단계를 실시하여 다기능 무알콜 소독제 조성물을 제조한다. 하기 표 1은 소독제 조성물 총 중량에 대한 각각의 성분 배합비를 표기한 것이다.A multifunctional alcohol-free disinfectant composition is prepared by performing the steps of preparing the first mixture according to the present invention as described above to obtaining the disinfectant composition. Table 1 below shows the mixing ratio of each component with respect to the total weight of the disinfectant composition.
<시험 예 1><Test Example 1>
상기 실시 예에 의해 제조되는 다기능 무알콜 소독제 조성물의 유효성분으로 함유되는 정향의 항균 활성 시험을 실시한다. The antibacterial activity test of cloves contained as an active ingredient of the multifunctional alcohol-free disinfectant composition prepared according to the above example is carried out.
항균 시험에 사용된 균주는 하기 표 2에 표시한 바와 같이 그람 양성균인 리스테리아(Listeria)와 그람 음성균인 대장균(Excheri chia coli)를 사용하였다.As the strains used for the antibacterial test, as shown in Table 2 below, the gram-positive bacteria Listeria and the gram-negative bacteria E. coli (Excheri chia coli) were used.
항균 활성을 측정하기 위해 디스크 확산법을 실시하였다. 디스크 확산법을 시험하기 하루 전에 각각의 균주를 Luria-bertari broth (LB) 5mL에 24시간 동안 200rpm으로 배양한 후 사용하였으며, 균수를 1×106cfu/mL로 사용하였다. 고체배지에 골고루 도말된 페트리 접시에 추출물을 최동 농도가 5, 10mg이 되도록 처리하여 완전히 흡수시킨 후 37℃ 인큐베이터에서 24시간 배양하여 시료 처리 주위의 inhibition zone(nm)의 직경을 측정하였다. 하기 도 1은 대장균(a)와 리스테리아(b)에서의 배양 결과 이미지를 도시한 것이다. zone이 존재하면 활성이 있으며 zone이 클 수록 활성이 강하다는 의미이므로 도 1의 배양 결과 이미지를 통해서 정향의 항균 활성 작용이 활발하게 이루어지는 것을 확인할 수 있다.A disk diffusion method was performed to measure the antibacterial activity. One day before the disc diffusion method, each strain was cultured in 5 mL of Luria-bertari broth (LB) at 200 rpm for 24 hours, and the number of bacteria was used at 1×10 6 cfu/mL. The extract was treated so that the maximum concentration was 5 or 10 mg in a Petri dish spread evenly on a solid medium, and after complete absorption, incubated in an incubator at 37° C. for 24 hours to measure the diameter of the inhibition zone (nm) around the sample treatment. 1 shows an image of a culture result in E. coli (a) and Listeria (b). If the zone is present, there is activity, and the larger the zone, the stronger the activity. Therefore, it can be confirmed that the antibacterial activity of cloves is actively performed through the culture result image of FIG. 1 .
<시험 예 2><Test Example 2>
상기 실시 예에 의해 제조되는 다기능 무알콜 소독제 조성물의 유효성분으로 함유되는 정향 추출물 및 포공영 추출물을 함유하는 니오좀의 입자 크기 분석 시험을 실시한다. 하기 도 2는 니오좀의 입자 크기 분포 그래프 및 평균 입도 측정 결과를 도시한 것이다. 니오좀 입자가 나노 수준으로 조성되면 유효성분의 전달력 및 침투력이 현저히 증가하는 바, 도 2의 결과를 통해 본 발명에 따른 정향 추출물 및 포공영 추출물을 함유하는 니오좀 입자의 평균 입도가 86.0nm 수준인 것을 확인할 수 있다.A particle size analysis test of niosomes containing clove extract and pogongyeong extract contained as an active ingredient of the multifunctional non-alcoholic disinfectant composition prepared by the above example is conducted. 2 is a graph showing a particle size distribution graph and average particle size measurement results of niosomes. When the niosome particles are composed at the nano level, the delivery power and penetration power of the active ingredient are significantly increased, and the average particle size of the niosome particles containing the clove extract and pogongyeong extract according to the present invention is 86.0 nm through the results of FIG. 2 . It can be confirmed that
<시험 예 3><Test Example 3>
상기 실시 예에 의해 제조되는 다기능 무알콜 소독제 조성물의 살균력 측정 시험을 실시한다. A test for measuring the sterilization power of the multifunctional alcohol-free disinfectant composition prepared according to the above example is carried out.
살균력 시험에 사용된 접종균주는 녹농균(Pseudomonas aeruginosa), 살모넬라균(Salmonella Typhimurium), 고초균(Bacillus subtilis)를 사용하였다.Inoculation strains used for the sterilization test were Pseudomonas aeruginosa, Salmonella Typhimurium, and Bacillus subtilis.
시험액은 본 발명에 따른 다기능 무알콜 소독제 조성물 샘플 1mL(g) : 시험 균액 0.1mL로 하며, 대조시험액은 PBS(Phosphate Buffer Saline) 1mL : 시험 균액 0.1mL로 한다.The test solution is 1 mL (g) of the multifunctional non-alcoholic disinfectant composition sample according to the present invention: 0.1 mL of the test bacteria solution, and the control test solution is PBS (Phosphate Buffer Saline) 1 mL: 0.1 mL of the test bacteria solution.
샘플과 각각의 시험 균액을 혼합 후 5분 경과 뒤 확산 배양한다. 시료채취량은 1mL이며 생균수를 측정하기 위하여 10 fold serial dilution하고 희석액을 각각 0.1ml 취하여 확산 배양하는 과정을 2회 반복하며, TSA배지를 사용하여 37℃에서 22±2h 동안 배양한 후 균수를 카운트하여 시험한다. 대조시험액 역시 샘플과 동일한 방법으로 시험한다. 하기 도 3 내지 도 5 및 표 3의 시험 결과를 통해서 본 발명에 따른 다기능 무알콜 소독제 조성물의 살균력이 탁월한 결과를 나타냄을 확인할 수 있다.After mixing the sample and each test microbial solution, diffusion culture is performed after 5 minutes. The sample collection amount is 1mL, and in order to measure the number of viable cells, 10 fold serial dilution, 0.1 ml of each dilution, and diffusion culture are repeated twice. After culturing at 37°C for 22±2h using TSA medium, the number of bacteria is counted. to test The control test solution is also tested in the same way as the sample. Through the test results of FIGS. 3 to 5 and Table 3, it can be confirmed that the sterilizing power of the multifunctional alcohol-free disinfectant composition according to the present invention exhibits excellent results.
균주exam
strain
시간contact
hour
이상에서와 같은 본 발명에 따른 다기능 무알콜 소독제 조성물 및 조성물 제조방법은 프로폴리스, 정향, 포공영을 유효성분으로 함유하는 무알콜 소독제 조성물을 제조하도록 구성함으로써 약 60 ~ 80%가 알콜 성분으로 이루어진 종래의 소독제에 비해 저자극적이면서도 살균력이 우수한 소독제 조성물을 제공할 수 있는 이점이 있다.The multifunctional non-alcoholic disinfectant composition and composition manufacturing method according to the present invention as described above is configured to prepare an alcohol-free disinfectant composition containing propolis, cloves, and pogongyeong as active ingredients, so that about 60 to 80% of the conventional disinfectant consists of an alcohol component. There is an advantage in that it is possible to provide a disinfectant composition that is hypoallergenic and has excellent sterilization power.
또한, 본 발명은 유효성분의 효과적인 작용을 도출하도록 비이온성 계면활성제를 활용한 이중막 수송체인 니오좀 기술을 적용하여 나노 크기의 유효성분 전달체계를 형성함으로써 높은 탄력성 및 분산 안정성을 가지는 제형의 소독제 조성물을 제조하는 이점이 있다.In addition, the present invention is a disinfectant of a formulation having high elasticity and dispersion stability by forming a nano-sized active ingredient delivery system by applying niosome technology, which is a double-membrane transporter using a non-ionic surfactant to derive an effective action of the active ingredient. There are advantages to preparing the composition.
따라서, 본 발명은 종래 기술에 따른 소독제에 비해 높은 피부친화력 및 침투력을 제공하고 사용감 및 살균력이 우수하며 유효성분의 산화 및 변성을 방지하여 효력의 지속성이 향상된 고품질의 다기능 무알콜 소독제 조성물을 제공하는 효과가 있다.Therefore, the present invention provides a high-quality, multi-functional alcohol-free disinfectant composition with improved durability by preventing oxidation and denaturation of active ingredients, which provides high skin affinity and penetration, has excellent feeling and sterilization power, compared to disinfectants according to the prior art. there is
해당없음.Not applicable.
Claims (2)
상기 정향 추출물을 함유하는 니오좀 및 포공영 추출물을 함유하는 니오좀 입자의 평균 입도는 50 ~ 500nm인 것을 특징으로 하는 다기능 무알콜 소독제 조성물.10 to 20 parts by weight of propolis extract, 8 to 9 parts by weight of niosome containing clove extract, 3 to 5 parts by weight of niosome containing pogongyeong extract, 5 to 7 parts by weight of glycerin, and 1.2-hexanediol 2.5 to 3.5 parts by weight, 10 to 20 parts by weight of sodium salicylate, 4.5 to 5.5 parts by weight of disodium EDTA, 0.5 to 1 part by weight of methylpropanediol, 1.5 to 2.5 parts by weight of menthol, and butylene; Lycol 2.5 to 3.5 parts by weight, polysorbate-20 3 to 5 parts by weight, and the remaining amount of electrolyzed water,
The multifunctional alcohol-free disinfectant composition, characterized in that the average particle size of the niosome containing the clove extract and the niosome particle containing the pogongyeong extract is 50 ~ 500nm.
프로폴리스와, 부틸렌글라이콜과, 폴리소르베이트-20을 45℃에서 5분간 교반하여 제2혼합물을 수득하는 단계와,
상기 제1혼합물에 제2혼합물을 첨가하여 1차조성물을 조성하는 단계와,
상기 1차조성물에 정향 추출물을 함유하는 니오좀과, 포공영 추출물을 함유하는 니오좀과, 다이소듐이디티에이와, 멘톨과, 차아염소산나트륨과, 메틸프로판디올을 첨가하고 실온에서 10분간 혼합하여 2차조성물을 수득하는 단계와,
상기 2차조성물을 실온으로 냉각하고 180 ~ 220메쉬 필터로 여과하는 단계와,
상기 여과된 2차조성물을 저장 및 숙성하여 소독제 조성물을 수득하는 단계를 포함하는 다기능 무알콜 소독제 조성물 제조방법.A first mixture is prepared by stirring sodium salicylate, glycerin, and 1.2-hexanediol at room temperature for 10 to 20 minutes;
Stirring propolis, butylene glycol, and polysorbate-20 at 45° C. for 5 minutes to obtain a second mixture;
adding a second mixture to the first mixture to form a primary composition;
Niosome containing clove extract, niosome containing clove extract, disodium EDTA, menthol, sodium hypochlorite, and methylpropanediol were added to the primary composition and mixed at room temperature for 10 minutes. obtaining a secondary composition;
Cooling the secondary composition to room temperature and filtering with a 180-220 mesh filter;
A method for producing a multifunctional alcohol-free disinfectant composition comprising the step of obtaining a disinfectant composition by storing and aging the filtered secondary composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200049690A KR20210131527A (en) | 2020-04-24 | 2020-04-24 | Multifunctional non-alcoholic sanitizer and its manufacturing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200049690A KR20210131527A (en) | 2020-04-24 | 2020-04-24 | Multifunctional non-alcoholic sanitizer and its manufacturing method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20210131527A true KR20210131527A (en) | 2021-11-03 |
Family
ID=78505230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200049690A Abandoned KR20210131527A (en) | 2020-04-24 | 2020-04-24 | Multifunctional non-alcoholic sanitizer and its manufacturing method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20210131527A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101196113B1 (en) | 2010-12-07 | 2012-10-30 | 전라남도 | Method for manufacturing HandWash and HandWash composition Thereof containing natural oriental plant extracts |
KR101284045B1 (en) | 2005-09-22 | 2013-07-09 | 니치유 가부시키가이샤 | Gel-type disinfectant for fingers |
KR101583850B1 (en) | 2008-03-07 | 2016-01-08 | 킴벌리-클라크 월드와이드, 인크. | Moisturizing hand sanitizer |
KR101653436B1 (en) | 2009-05-22 | 2016-09-01 | 트리스텔 피엘씨 | Hand sanitizer |
-
2020
- 2020-04-24 KR KR1020200049690A patent/KR20210131527A/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101284045B1 (en) | 2005-09-22 | 2013-07-09 | 니치유 가부시키가이샤 | Gel-type disinfectant for fingers |
KR101583850B1 (en) | 2008-03-07 | 2016-01-08 | 킴벌리-클라크 월드와이드, 인크. | Moisturizing hand sanitizer |
KR101653436B1 (en) | 2009-05-22 | 2016-09-01 | 트리스텔 피엘씨 | Hand sanitizer |
KR101196113B1 (en) | 2010-12-07 | 2012-10-30 | 전라남도 | Method for manufacturing HandWash and HandWash composition Thereof containing natural oriental plant extracts |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2937101A1 (en) | Semi-fluidic composition for lubricating, moisture retaining, disinfecting, sterilizing and method using the same | |
KR20160079473A (en) | Preparation method of cleaning or disinfecting composition having antiviral activity by containing green tea extract as active component | |
AU2016296150A1 (en) | Antimicrobial compositions and formulations releasing hydrogen peroxide | |
JP2018520985A (en) | Antibacterial Chinese medicine composition, method for producing the same | |
KR20180054177A (en) | Eco-friendly hand-disinfectant composition containing extracts of natural material | |
KR102373422B1 (en) | Composition for vaginal cleaning including functional peptides | |
CN106377439A (en) | Anticorrosive composition without any chemically synthesized preservative and application thereof, and cosmetics prepared from anticorrosive composition | |
KR102308571B1 (en) | Functional cleaning agent containing sand pear extract | |
KR100942145B1 (en) | Soap composition for acne treatment containing ginseng absolute essential oil | |
KR102271989B1 (en) | Preparation method of chamaecyparis obtusa essential oil extract and antimicrobial composition comprising thereof | |
CN105012581A (en) | Fresh aloe antibacterial composite, application and preparing method of fresh aloe antibacterial composite | |
KR101674512B1 (en) | Cosmetic composition with effect of proliferation of lactic acid bacteria and anti-bacterial activity and manufacturing method thereof | |
KR20160079459A (en) | Cleaning or disinfecting composition having antiviral activity by containing green tea extract as active component | |
CN109674702B (en) | Clove compound natural preservative, preparation method and application in cosmetics | |
CN103110541A (en) | All-natural washing-free disinfectant hand sanitizer | |
CN111481567A (en) | Compound ozone oil and preparation method and application thereof | |
CN108938486B (en) | Anticorrosive composite and its preparation method and application | |
KR20210131527A (en) | Multifunctional non-alcoholic sanitizer and its manufacturing method | |
KR101862628B1 (en) | A composition of skin lubicant preparation and the method therefor | |
CN111821286B (en) | Liquid invisible mask with broad-spectrum bacteriostasis and preparation method and use method thereof | |
CN113368007B (en) | Multifunctional aerosol for oral cavity and preparation process thereof | |
JPWO2008032847A1 (en) | Topical skin preparation | |
KR20170136478A (en) | Skin external composition having excellent bactericidal activities | |
CN108685802B (en) | Anticorrosive composite and its preparation method and application | |
CN110917103A (en) | Ectoin and plant fermentation raw stock composition for balancing skin microecology and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20200424 |
|
PA0201 | Request for examination | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20210614 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20211220 |
|
PC1904 | Unpaid initial registration fee |